SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-003247
Filing Date
2015-01-07
Accepted
2015-01-07 06:04:37
Documents
8
Period of Report
2015-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d848792d8k.htm 8-K 22266
2 EX-1.1 d848792dex11.htm EX-1.1 211093
3 EX-5.1 d848792dex51.htm EX-5.1 10515
4 EX-99.1 d848792dex991.htm EX-99.1 6594
5 EX-99.2 d848792dex992.htm EX-99.2 4180
6 GRAPHIC g848792g69c14.jpg GRAPHIC 3623
7 GRAPHIC g848792g73h74.jpg GRAPHIC 3537
8 GRAPHIC g848792g80r86.jpg GRAPHIC 2223
  Complete submission text file 0001193125-15-003247.txt   269164
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36070 | Film No.: 15512031
SIC: 2834 Pharmaceutical Preparations